Karagiannis D, et al. – This study gauged the role of age as a prognostic factor for the outcome of myopic choroidal neovascularization (CNV) therapy with intravitreal ranibizumab injections. A notable influence was noted of age on the visual outcome of myopic CNV treatment with ranibizumab. Younger patients required fewer intravitreal injections and achieved a more marked improvement in vision.